Question 1

What are Interleukin-2 Receptor Blocking Antibody drugs?

Accepted Answer

Interleukin-2 Receptor Blocking Antibody drugs are pharmacologic agents that share a common mechanism (typically targeting Interleukin-2 receptor). 1 are currently marketed, with 0 more in clinical development.

Question 2

What are the marketed Interleukin-2 Receptor Blocking Antibody drugs?

Accepted Answer

Marketed Interleukin-2 Receptor Blocking Antibody drugs include Zenapax.

Interleukin-2 Receptor Blocking Antibody

Targets

Marketed (1)